These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 16564796
1. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Thompson JT. Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796 [Abstract] [Full Text] [Related]
2. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM. Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834 [Abstract] [Full Text] [Related]
3. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years. Islam MS, Vernon SA, Negi A. Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927 [Abstract] [Full Text] [Related]
5. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB. Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [Abstract] [Full Text] [Related]
6. Adverse events after intravitreal triamcinolone in patients with and without uveitis. Galor A, Margolis R, Brasil OM, Perez VL, Kaiser PK, Sears JE, Lowder CY, Smith SD. Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594 [Abstract] [Full Text] [Related]
15. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. Im L, Allingham RR, Singh I, Stinnett S, Fekrat S. J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759 [Abstract] [Full Text] [Related]